Jay Feingold

Jay Feingold

Plus aucun poste en cours

Fortune : 1 M $ au 30/04/2024

67 ans
Health Technology
Consumer Services

Provenance du réseau au premier degré de Jay Feingold

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 16
Public Company Pharmaceuticals: Major 12
9
Private Company Pharmaceuticals: Major 9

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Jay Feingold via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
University of California San Diego College/University

Mark Chin

Susan Romanus

Kenneth Lock

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

PFIZER, INC. Pharmaceuticals: Major

Karen Dawes

Freda Lewis-Hall

Jennifer Ruff

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Investor Relations Contact

GILEAD SCIENCES, INC. Biotechnology

Mark Chin

Kenneth Lock

Corporate Officer/Principal

Sales & Marketing

AMGEN INC. Pharmaceuticals: Major

Darren Cline

Kenneth Lock

Sales & Marketing

Corporate Officer/Principal

College/University

David Steinberg

Kenneth Lock

Undergraduate Degree

Masters Business Admin

MERCK & CO., INC. Pharmaceuticals: Major

Michael Kamarck

Sanat Chattopadhyay

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

David Steinberg

Mark Chin

Market Strategist

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

Freda Lewis-Hall

Rachel Humphrey

Corporate Officer/Principal

Corporate Officer/Principal

University of Tokyo College/University

Kunio Ishihara

Hiroshi Hirabayashi

Graduate Degree

Graduate Degree

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Freda Lewis-Hall

Rachel Humphrey

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Pharmaceuticals: Major

Karen Dawes

Robert Essner

Sales & Marketing

Chief Executive Officer

JAPAN POST HOLDINGS CO., LTD. Life/Health Insurance

Yoshifumi Nishikawa

Kunio Ishihara

President

Director/Board Member

Medical/Nursing Services

Sukumar Nagendran

Chief Tech/Sci/R&D Officer

The Wharton School of the University of Pennsylvania College/University

Mark Chin

Masters Business Admin

ARIX BIOSCIENCE PLC Investment Managers

Mark Chin

Chief Investment Officer

Pharmaceuticals: Major

Mark Chin

Director/Board Member

Financial Conglomerates

Mark Chin

Director/Board Member

AURA BIOSCIENCES, INC. Biotechnology

Mark Chin

Director/Board Member

Miscellaneous Commercial Services

Mark Chin

Director/Board Member

Biotechnology

Mark Chin

Director/Board Member

Biotechnology

Sukumar Nagendran

Director/Board Member

DISC MEDICINE, INC. Biotechnology

Mark Chin

Director/Board Member

Investment Managers

Mark Chin

Private Equity Investor

Longitude Capital

Mark Chin

Corporate Officer/Principal

Miscellaneous Commercial Services

Mark Chin

Director/Board Member

Biotechnology

Mark Chin

Director/Board Member

Investment Managers

Mark Chin

Private Equity Investor

Rutgers State University of New Jersey College/University

Sukumar Nagendran

Undergraduate Degree

QUEST DIAGNOSTICS INCORPORATED Services to the Health Industry

Sukumar Nagendran

Corporate Officer/Principal

REATA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Sukumar Nagendran

Corporate Officer/Principal

SOLID BIOSCIENCES INC. Biotechnology

Sukumar Nagendran

Director/Board Member

Biotechnology

Sukumar Nagendran

Director/Board Member

TAYSHA GENE THERAPIES, INC. Biotechnology

Sukumar Nagendran

President

Investment Trusts/Mutual Funds

Sukumar Nagendran

Corporate Officer/Principal

HARPOON THERAPEUTICS, INC. Biotechnology

Mark Chin

Director/Board Member

ITERUM THERAPEUTICS PLC Pharmaceuticals: Major

Mark Chin

Director/Board Member

Pharmaceuticals: Major

Toshiaki Tojo

President

Pharmaceuticals: Major

Rachel Humphrey

Corporate Officer/Principal

Pharmaceuticals: Major

Rachel Humphrey

Corporate Officer/Principal

College/University

Rachel Humphrey

Doctorate Degree

College/University

Rachel Humphrey

Undergraduate Degree

MIRATI THERAPEUTICS Biotechnology

Rachel Humphrey

Chief Tech/Sci/R&D Officer

Statistiques

Internationale

Etats-Unis 41
Japon 5
Royaume-Uni 3
Irlande 3
France 3

Sectorielle

Health Technology 30
Consumer Services 8
Finance 7
Commercial Services 5
Health Services 3

Opérationnelle

Director/Board Member 157
Corporate Officer/Principal 83
Independent Dir/Board Member 39
Undergraduate Degree 23
Chief Tech/Sci/R&D Officer 21
  1. Bourse
  2. Insiders
  3. Jay Feingold
  4. Connexions Sociétés